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Abstract
Background: Development of lung alveolar sacs of normal structure and size at late gestation is
necessary for the gas exchange process that sustains respiration at birth. Mice lacking the lung
differentiation gene T1α [T1α(-/-)] fail to form expanded alveolar sacs, resulting in respiratory
failure at birth. Since little is known about the molecular pathways driving alveolar sacculation, we
used expression microarrays to identify genes altered in the abnormal lungs and, by inference, may
play roles in normal lung morphogenesis.
Results:  Altered expression of genes related to cell-cell interaction, such as ephrinA3, are
observed in T1α(-/-) at E18.5. At term, FosB, Egr1, MPK-1 and Nur77, which can function as
negative regulators of the cell-cycle, are down-regulated. This is consistent with the
hyperproliferation of peripheral lung cells in term T1α (-/-) lungs reported earlier. Biochemical
assays show that neither PCNA nor p21 are altered at E18.5. At term in contrast, PCNA is
increased, and p21 is decreased.
Conclusion: This global analysis has identified a number of candidate genes that are significantly
altered in lungs in which sacculation is abnormal. Many genes identified were not previously
associated with lung development and may participate in formation of alveolar sacs prenatally.
Background
Lung development starts in mice at embryonic day 9.5
(E9.5). By E16.5, airways have extensively grown and
branched to form the bronchial tree. Between E16.5 and
term (E20.5) lung cell proliferation is gradually reduced,
and the distal lung undergoes significant morphogenetic
changes to form the alveolar sacs. While a population of
distal epithelial cells flattens, thins, and spreads to form
type I cells, other distal epithelial cells remain cuboidal,
acquire surfactant filled lamellar bodies and differentiate
into type II cells. Differentiation of epithelial cells is
accompanied by vascular remodeling and thinning of the
mesenchyme, and results in enlargement of the diameter
and surface area of the alveolar sacs. Overall this process
is known as sacculation, and it is critical to increase the
efficiency of fluid absorption and gas exchange processes
at birth [1-3].
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Very little is known about the molecular regulation of sac-
culation in normal animals. Abnormal sacculation has
been reported in many genetically altered animals carry-
ing null mutations, or transgenes that mis- or over-express
growth factors, transcription factors, and other regulatory
molecules. These molecular abnormalities result in for-
mation of alveolar spaces that are either too small, as in
glucocorticoid receptor (GR) [4], corticotropin releasing
hormone (CRH) [5], and Sp3 knockout mice [6], and
double p21(+/-)p57(+/-) and p21(-/-)p57(+/-) mice [7],
or too large as in gp330 knockout mouse [8], the SP-C
promoter-Bmp4 mouse [9], and SP-C promoter-GATA6
mouse [10]. It is interesting that both extremes of alveolar
sac size can result in death of the newborn shortly after
birth due to respiratory failure. Collectively these observa-
tions suggest that formation of alveolar sacs of appropri-
ate dimensions, surface area, and thickness is of
fundamental importance in lung organogenesis and is
critical for survival.
We have previously shown that mice carrying a null muta-
tion of the T1α gene fail to form expanded alveolar sacs
near term and die at birth due to an inability to inflate
their lungs with the first few breaths [11]. In normal late
fetal and adult lungs, T1α protein is uniquely expressed in
the apical membrane of type I alveolar epithelial cells,
which form over 90% of the alveolar surface that is spe-
cialized for gas exchange [12-14]. In the absence of this
protein the alveolar sacs still form but they are narrower
than normal and do not properly expand at birth. This
abnormality appears to be linked to deficient differentia-
tion of type I cells. This was indicated by the presence of
fewer attenuated type I cells and reduced expression of
Aqp-5, another type I cell marker gene. Secreted surfactant
and surfactant gene expression patterns indicate normal
differentiation of type II cells in T1α (-/-) lungs.
Some insights into the process of alveolar sacculation in
normal animals come from gene expression microarray
data using lungs of normal mice at different developmen-
tal time points from embryonic day 9 through postnatal
week 4 [15]. This study shows marked changes in gene
expression between fetal day 17 and newborn, a period
that encompasses the process of sacculation. Among the
genes altered are the transcription factors Pod1 and
GATA6, the stress-related gene Cyr61, surfactant protein
D, and caveolin-1α. However, this important survey was
not designed specifically to study sacculation, which
would require sampling at more frequent time points near
term.
As an alternative approach for understanding the molecu-
lar regulation of sacculation, it is reasonable to compare
lungs with normal alveolar sac formation to those with
altered sac formation and infer from differences in gene
expression a set of candidate genes involved in the proc-
ess. Preliminary expression microarray analysis of the GR
knockout lung [16] has explored the overall changes in
gene expression that lead to alterations in alveolar sac for-
mation. This approach has also been used to study the
related process of alveologenesis, that involves formation
of septae that 'subdivide' alveolar sacs into smaller units
or true alveoli [17].
Here, we use a microarray approach to begin to under-
stand the molecular mechanisms by which formation of
alveolar sacs is altered in T1α null mice, animals that serve
as a highly reproducible model of altered lung saccula-
tion. We have identified genes that are preferentially
altered in the T1α null lung prior to recognizable struc-
tural abnormalities, such as ephrinA3, and identified that
a number of regulators of the cell cycle are altered at term.
Our study also shows that p21, a negative cell cycle regu-
lator, is decreased at term but not at E18.5 at both the
mRNA and protein levels, a finding that is likely associ-
ated with the failure of sacculation. These genes are now
candidates for future studies designed to understand the
molecular mechanisms that regulate sacculation in the
normal lung.
Results
Altered alveolar sac morphology in the absence of T1α is 
evident on fetal day E18.5
T1α protein is expressed in the apical surface of lung epi-
thelial cells throughout mouse development (Figure 1).
To determine the timing of the initial phenotypic altera-
tions in the absence of T1α, we analyzed the distal lung
morphology of T1α(+/+) and T1α(-/-) lungs at E11.5,
15.5, 18.5, and 19.5. Histological analyses showed no dif-
ferences between T1α(+/+) and T1α(-/-) lungs at E11.5
and E15.5 (Fig. 2A,B,E,F). Gross morphology of the lobes
and size of the epithelial buds are similar in (+/+) and (-/
-) lungs at E11.5. No significant difference in epithelial
tube number and size is apparent at E15.5 (Fig. 2I,L), sug-
gesting that branching morphogenesis is not altered in
T1α(-/-) lungs. In normal lung development, thinning of
the mesenchyme, epithelial type I cell flattening, and
enlargement of the air spaces are observed between E16.5
and term, as the alveolar sacs form. In the absence of T1α,
the abnormal phenotype is evident at E18.5 and becomes
progressively more severe at E19.5 (Fig. 2C,D,G,H) and at
term [11], as the alveolar sacs are very narrow and irregu-
lar and the mesenchyme appears thicker than normal (Fig.
2K,N).
Altered expression of PCNA and p21 genes
To determine whether morphological alterations
observed in the absence of T1α at E18.5 are also accompa-
nied by changes in cell proliferation, we compared expres-
sion of PCNA and p21 genes by northern and western blotBMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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analyses in (+/+), (+/-) and (-/-) lungs at E18.5 and term.
Neither PCNA nor p21 protein level is altered at E18.5 in
T1α(-/-) lungs compared to T1α(+/+) (Fig. 3A–C). How-
ever at term, p21 mRNA is reduced 3.6-fold in (-/-) lungs
(p ≤ 0.05) (Fig. 3B) and p21 protein is reduced to 75% of
the level in (+/+) lungs (p ≤ 0.05) (Fig. 3C). We have pre-
viously shown high numbers of PCNA-stained cells at
term, and that PCNA protein is significantly up-regulated
~1.8 fold in (-/-) lungs [11]. This trend is also observed in
Fig. 3A (~1.7 fold, Student's t-test p = 0.059). The mRNA
levels of other two members of the cdk inhibitor family,
p27 and p57 at term are not altered (Fig. 3D). These data
suggest that the increase in distal lung cell proliferation in
the absence of T1α occurs after morphological alterations
are evident, and is probably the consequence of earlier
changes in gene expression triggered by the absence of
T1α. In the microarray analysis neither p21 nor p27 are
detected as present (detection p > 0.05) precluding the
comparison to the northern blot analysis. PCNA and p57
are both detected as present in the microarrays (detection
p ≤ 0.05) and their levels of expression do not change in
the absence of T1α (-/-) compared to (+/+) at E18.5 or at
term (data not shown), similarly to the data obtained by
northern blots (Figure 3).
Changes in gene expression in T1α null mutant lungs
To identify genes potentially involved in the abnormal
alveolar sac formation of the T1α null lungs we analyzed
global gene expression profiles of T1α(-/-) vs. T1α(+/+)
lungs, at E18.5 and at term, using oligonucleotide micro-
arrays. The data were analyzed using Student's t-test and
the more stringent Mann-Whitney analysis [18]. We iden-
tified 239 genes that differ between (-/-) and (+/+) lungs
at E18.5, with Student's t-test p ≤ 0.05, and median detec-
tion p value ≤ 0.05 at least in one genotype (Table S1,
Additional file 3). Of those, 156 genes have a Mann-Whit-
ney p value ≤ 0.05 (Table S3, Additional file 3). Genes in
this group that are up (+) or down (-) regulated more than
1.5 fold with a Student's t-test p ≤ 0.05 and Mann-Whit-
ney p ≤ 0.05 are shown in Table 1. At term, there are 50
genes that change significantly with a Student's t-test p ≤
0.05 (Table S2, Additional file 3), Mann-Whitney p = 0.08
(Table S4, Additional file 3). The ability to detect genes
that change significantly between T1α (-/-) and (+/+) at
term was limited by the smaller sample size at that time
point (n = 3). Known genes in this group changing more
than 1.5 fold are shown in Table 2. The microarray quality
control parameters analyzed, described in the Methods
section, indicate that all hybridization experiments are
comparable and of good quality.
We used EASE bioinformatic tool to identify over-repre-
sented biological processes, defined by the Gene Ontol-
ogy database (GO), for 239 genes that have altered
expression at E18.5 and for the 50 genes altered at term in
the absence of T1α (data not shown). Genes involved in
vasculogenesis, protein targeting, protein metabolism and
mitosis are over-represented at E18.5 with an EASE score
≤ 0.05. Apoptosis, cell proliferation and regulation of
transcription are over-represented at term with an EASE
score ≤ 0.05. This analysis reflects the molecular events
that occur in fetal and term lung in the absence of T1α
during alveolar sac formation, and supports the finding
that altered proliferation is a late gestation event that may
be the result of earlier changes in gene expression in the
absence of T1α. These data also correlate with the
increased PCNA and reduced p21 protein expression
observed at term. Changes in gene expression between
T1α(-/-) and T1α(+/+) lungs either at E18.5 or at term are
significant (p ≤ 0.05; not corrected for multiple compari-
sons) but moderate, considering the major morphological
changes observed in the absence of T1α. We previously
Expression of T1α protein on the apical surface of mouse lung epithelial cells during development Figure 1
Expression of T1α protein on the apical surface of mouse lung epithelial cells during development. Immunohisto-
chemistry analysis of T1α protein using mAb 8.1.1 antibody in mouse lung paraffin sections. (A) At E11.5 T1α is expressed on 
the apical surface of epithelial cells in the forming lung bud, (B) at E15.5 it is expressed in the cuboidal epithelial cells of the dis-
tal lung, (C) at E18.5 alveolar epithelial cells are starting to flatten and T1α antibody labels the apical surface of the alveolar 
walls, and (D) at postnatal day 1, type I cells express T1α protein while type II cells are not labeled. Red arrows indicate T1α 
expression. Black arrowheads indicate unstained type II cells at late gestation. Bar = 25 µmBMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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showed that the absence of T1α alters differentiation of
type I epithelial cells but does not appear to affect other
cell types of the distal lung at term, such as type II cells or
endothelial cells [11]. Also, a similar proportion of epi-
thelial to mesenchymal cells in T1α(-/-) and (+/+) lungs is
suggested by unchanged levels of expression of the epithe-
lial markers cytokeratin 8 and 18 and the mesenchymal
marker collagen 1α1 at E18.5 and term (Figure S1, Addi-
tional file 1). Thus, molecular changes in an epithelial cell
population that accounts for ~10% of the cells of the lung
are likely to provide minimal signals when analyzed in the
context of total lung mRNAs or proteins. These small but
statistically significant changes are likely to be biologically
relevant. Likewise, the molecular alterations in the
absence of T1α could be at the post-transcriptional level.
We evaluated by real time RT-PCR (QRT-PCR) changes in
expression of selected genes identified by the microarray
analyses (Figure 4). We confirmed the trend in expression
observed in the microarrays for several genes, making
them good candidates for further studies. Many of the
genes have been previously described in the lung (see ref-
Lung phenotype in T1α null mice is apparent after E15.5 Figure 2
Lung phenotype in T1α null mice is apparent after E15.5. H & E staining of (A-D) T1α (+/+) and (E-H) T1α (-/-) lungs 
at E11.5, 15.5, 18.5, and 19.5 respectively Bar = 100 µm. (I-K) T1α (+/+) at E15.5, E18.5 and E19.5 (L-M) T1α (-/-) at E15.5, 
E18.5 and E19.5 Bar = 25 µm. Similar lung morphology is observed in T1α (+/+) and T1α (-/-) lungs at E11.5 and 15.5. The phe-
notype is more severe after E18.5. Thereafter, the lungs exhibit narrower airspaces and thicker mesenchyme. P, pleura; E, epi-
thelium; A, alveolar space.BMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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erences for Tables 1 and 2, Additional file 2, or the Uni-
Gene database,[19]), and are therefore potentially
involved in the formation of functional alveolar sacs.
At E18.5 we identified genes that are involved in cell-cell
interaction, cell motility, prostaglandin metabolism, and
signal transduction (Table 1). One of the genes involved
in cell-cell interaction and cell motility is ephrinA3, which
is up regulated at the mRNA and protein level (Figures
4A,B and 5A). Another member of the ephrin family,
ephrin B2, is down regulated (Table 1). Cytoplasmic
dynein, a motor protein involved in microtubule-medi-
ated forward cell migration [20], is up regulated in the
absence of T1α (Figure 4A,B). Genes involved in cell adhe-
sion are also altered, such as the extracellular matrix pro-
tein βig-h3, and VCAM1 (Table 1). Ptgs1 (prostaglandin
p21 and PCNA expression is altered at term but not at E18.5 in T1α null lungs Figure 3
p21 and PCNA expression is altered at term but not at E18.5 in T1α null lungs. (A) Representative western blot and 
densitometry analysis of PCNA in total lung protein extracts (10 µg) at E18.5 and term, (B) densitometry analysis of p21 north-
ern blots at term, (C) representative western blot and densitometry analysis of p21 in total lung protein extracts (10 µg) at 
E18.5 and term, and (D) representative blots of p21, p27 and p57 mRNA in total lung RNA at term (10 µg) normalized to β-
actin. Time points analyzed were E18.5 and term. (+/+) indicates wild type, (+/-) heterozygous, and (-/-) homozygous genotypes 
respectively. n = 3 of each time point and genotype. Bars represent mean. Error bars represent Standard Deviation. (*) indi-
cates p ≤ 0.05; (#) indicates p = 0.059.B
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Table 1: Genes differentially expressed in T1 α(-/-) vs T1 α(+/+) lungs at E18.5.
Microarrays
Gene Fold p Acc # Function Lung expression and References
Transcription factors
Sp1 -1.82 0.01 X60136 regulation of transcription (+) (E1)
Sox11 -1.64 0.05 AF009414 regulation of transcription (+) (E2)
Signal transduction
Insulin-like growth factor I -1.92 0.016 X04480 anti-apoptosis, organogenesis (+) (E3, E4)
Sp 17 -1.82 0.008 Z46299 cAMP-dependent protein kinase regulator (+) (E5, E6)
PKC delta 1.50 0.026 X60304 protein serine/threonine kinase activity (+) (E7)
Signal-induced proliferation assoc.1 1.72 0.011 D11374 regulation of cell cycle (+) UniGene Mm.3072
G protein gamma 3 linked 1.90 0.005 AF069954 RNA transport (+) UniGene Mm.345134
Pip5k2c 2.35 0.005 AV303514 (+) UniGeneMm.22682
Cytoskeleton/ECM
big-h3 -1.50 0.006 L19932 cell adhesion (+) (E8)
dynein, cytoplasmic 1.58 0.007 AF063229 microtubule-based movement (+) (E9)
Ion channels/transport
Chloride channel regulator Icln -1.86 0.03 U72059 chloride transport, regulation of cell volume (+) (E10)
Solute carrier family 31 1.50 0.002 AI839005 copper ion transporter (+) Unigene Mm.248637
Enzymes
YME1-like -2.33 0.008 AF090430 metalloendopeptidase activity (+) Unigene Mm.23335
Holocytochrome c synthetase -2.01 0.009 NM_008222 lyase (+) MGI:106911
Cytochrome P450, 51 -1.81 0.011 AW122260
Splicing factor 3a1 -1.69 0.044 AW120546 nuclear mRNA splicing, via spliceosome (+) UniGene Mm.156914
Phosphodiesterase 7A -1.62 0.0095 U68171 metal dependent phosphohydrolases (+) (E11)
Ring finger protein 13 -1.62 0.008 AF037205 ubiquitin-protein ligase activity (+) UniGene Mm.274360
Ptgs1 -1.54 0.008 M34141 prostaglandin biosynthesis (+) (E12)
Paraoxonase 2 1.50 0.02 L48514 arylesterase activity (+) (E13)
Protease serine 3 1.53 0.034 AE000665 n.d.
Cytochrome P450 4v3 1.57 0.006 BC026957 (+) UniGene Mm.245297
Branched chain aminotransferase 2 1.66 0.013 AF031467 amino acid biosynthesis (+) UniGene Mm.24210
Neuropsin 1.74 0.011 D30785 serine-type endopeptidase activity (+) (E14)
Catalase 1 1.80 0.016 AV083603 response to oxidative stress (+) (E15)
Thioether S-methyltransferase 1.99 0.012 M88694 methyl transferase activity (+) (E16)
Immune system
Histocompatibility 2, D1 1.54 0.002 M69069 antigen presentation (+) UniGene Mm.33263
Complement C1qa 1.82 0.004 X58861 complement activation (+) UniGene Mm.370
Complement C1q B chain 1.82 0.023 M22531 complement activation (+) UniGene Mm.2570B
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Ubiquitination/Degradation system
Proteasome (macropain) alpha 2 -2.08 0.046 X70303 ubiquitin-dependent protein catabolism (+) UniGene Mm.252255
Tetratricopeptide repeat gene -1.75 0.029 AJ002730 (+) (E17)
Ube2v2 -1.58 0.022 NM_023585 ubiquiting conjugating enzyme activity (+) UniGene Mm.235407
Transcription/Translation/Protein synthesis
Eukaryotic translation initiation fac.2A -2.15 0.017 AW061243 regulation of protein biosynthesis (+) UniGene Mm.196220
FK506-binding protein (FKBP23) -1.82 0.011 AF040252 peptidyl-prolyl isomerase (+) (E18)
Eukaryotic translation initiation fac.1A -1.72 0.036 AI132207 translation factor activity (+) UniGene Mm.262037
Cell Adhesion/Migration
Vascular cell adhesion molecule 1 -1.52 0.032 M84487 cell-cell adhesion (+) (E19)
Apoptosis
Programmed cell death 4 -1.54 0.014 D86344 isomerase n.d.
Cell-cell interaction
Sema4b -1.69 0.047 AA266467 cell differentiation, development n.d.
Ephrin B2 -1.64 0.011 U30244 development, neurogenesis, organogenesis (+) (E21)
Ephrin A3 1.50 0.006 U92885 cell atraction-repulsion (+) UniGene Mm.331159
Other
Exportin1/CRM1 homolog -2.00 0.009 AW123788 protein-nucleus export (+) UniGene Mm.217547
NMDA receptor-regulated gene 1 -1.92 0.021 AW260482 angiogenesis, cell differentiation (+) UniGene Mm.275281
Smarca5 -1.83 0.05 AA794509 chromatin remodeling (+) (E22)
NP220 -1.81 0.008 D83033 RNA binding (+) UniGene Mm.132392
Angiomotin -1.78 0.042 AI854771 cell migration (+) UniGene Mm.100068
IL13 receptor alpha 1 -1.67 0.02 AA608387 cytokine receptor activity (+) UniGene Mm.24208
Kidney cell derived transcript -1.69 0.008 U13371 myoD family inhibitor domain containing (+) UniGene Mm.1314
Single strand DNA binding protein -1.69 0.016 AA881160 DNA replication n.d.
Rnpc2 -1.61 0.018 AA688834 transcription co-activator (+) UniGene Mm.153895
ZAP3 -1.61 0.008 AB033168 differentiation (+) UniGene Mm.153183
ADP-ribosylation-like factor 6 IP2 -1.57 0.02 AA763874 GTP-binding protein (+) UniGene Mm.175403
Phosphatidylinositol glycan, class A -1.59 0.025 D31863 GPI-anchor byosynthesis (+) UniGene Mm.3781
Quaking -1.56 0.04 U44940 vasculogenesis, locomotory behavior (+) UniGene Mm.262294
WSB-1 -1.52 0.023 AF033186 signaling (+) UniGene Mm.307022
Sorting nexin 17 1.51 0.037 AW123761 receptor mediated endocytosis (+) UniGene Mm.6118
Disabled homolog 2 interacting protein 1.60 0.03 AI837497 GTPase activating protein (+) UniGene Mm.29629
Zinc finger protein 64 1.73 0.026 U49046 development, transcription (+) UniGene Mm.2095
Ribosomal protein L22 1.77 0.004 AI853960 ribosome biogenesis (+) UniGene Mm.259907
Student's t test ≤ 0.05, Mann-Whitney p ≤ 0.05, detection p ≤ 0.05; UniGene = Expression profile suggested by analysis of EST counts; (+) lung expression
Microarray n = 5, Fold negative = down-regulated genes; Fold positive = up-regulated genes. nd.= no detected; (E) references in supplemental material
Table 1: Genes differentially expressed in T1 α(-/-) vs T1 α(+/+) lungs at E18.5. (Continued)BMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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synthase 1; Cox-1) mRNA and protein expression levels
are reduced in the absence of T1α (Table 1, and Figure
5B). Overall these changes in gene expression suggest that
a different reorganization of the cellular structure is taking
place in (-/-) lungs compared to wild type at E18.5.
At term, expression of several genes involved in regulation
of cell proliferation is altered (Table 2). Among these, the
early response genes FosB, Egr1, MPK-1 and Nur77 are
down regulated (Figure 4C,D).
Some genes tested by QRT-PCR showed a variable level of
expression in different T1α(-/-) lungs, such as Sp1 and Rb
(data not shown). This is likely due to differences in the
penetrance of the phenotype [11] within independent
samples isolated in different experiments. The down-reg-
ulation of the expression of Cyr61 mRNA observed in the
microarray analysis was not validated by other methods
and Cyr61 protein level is significantly up-regulated in the
absence of T1α (data not shown). This finding under-
scores the fact that changes in mRNA levels do not always
correlate with changes in protein expression.
Discussion
We have used the T1α knock-out mouse lung as a model
of failed alveolar sacculation to begin to discover what
genes are involved in the regulation of this critical mor-
phogenetic event before birth. We previously reported
that at term, lungs of the T1α knockout mouse display a
severe phenotype [11], with airspaces that are small and
often tortuous. The small airspaces cannot be expanded
under positive pressure, indicating that the peripheral
lung surface area is underdeveloped. Despite this dramatic
phenotype, the null lungs at term have many normal fea-
tures, including a normal number of type II alveolar epi-
thelial cells, normal expression levels of surfactant protein
mRNAs (SP-A, -B, -C, and -D), of a bronchiolar cell
marker (CCSP), and of selected growth factors including
FGF7 and FGF10 [11]. Of the genes tested, only aquaporin
5, another type I cell membrane protein, is reduced at
Table 2: Genes differentially expressed in T1 α(-/-) vs T1 α (+/+) lungs at term.
Microarrays
Gene Fold p Acc # Function Lung expression and 
References
Transcription factors
Egr1 -3.6 0.013 M28845 early response gene (+) (E23, E24)
Nr4A1/Nur77 -2.4 0.050 X16995 modulation of RA signaling (+) (E25, E26)
FosB -1.6 0.023 X14897 regulation of cell cycle (+) (E27)
Rb1 -1.5 0.048 AV338260 negative regulation of cell cycle (+) (E28)
Signal transduction
MKP-1 -1.6 0.042 X61940 MAPK phosphatase; cell cycle (+) (E29)
PKCα binding protein 1.5 0.043 AV056986 kinase activity n.d.
Cell signaling
Cyr61 -2.8 0.0009 M32490 cell adhesion; growth factor bp (+) (E30)
Ion channels/transport
Cation channel C6 -2.0 0.030 U49069 Ca2+ transport (+) (E33)
ATPase, H+ transp. V1B2 -1.6 0.011 U13838 Cl-, H+ transporter; ATPase (+) (E34)
Enzymes
Leucine aminopeptidase 3 -1.6 0.049 AI839225 proteolysis and peptidolysis n.d.
Immune system
IFN activated gene 205 -1.8 0.048 M74123 n.d.
Other
S100a9 -1.9 0.035 M83219 calcium ion binding (+) (E35)
Tumor differentially expressed 2 -1.5 0.025 AI834772 (+) UniGene Mm.29344
Additional sex combs like 1 1.8 0.032 AI852340 regulation of transcription n.d.
Gas5 3.0 0.007 AI849615 negative control of cell growth (+) (E36)
Student's t ≤ test 0.05, Mann-Whitney p = 0.08, detection p ≤ 0.05; n.d. not determined; (+) lung expression
Microarray n = 3; Fold negative = down-regulated genes; Fold positive = up-regulated genes; (E) references in supplemental materialBMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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both the mRNA and protein level. PCNA protein, a
marker of post-proliferative cells, is increased at birth as
was expected given the hyperproliferative phenotype of
the term animals.
Several other genetically altered animals have shown a
failure of sacculation resulting in lung histology that
resembles the T1α deficient mice. The genes targeted in
these animals therefore become candidates for key players
in the process of sacculation. These include the transcrip-
tion factors Sp3 [6] and NF1B [21], hormones and hor-
mone receptors CRH [5] and GR [4], and inhibitors of the
cell cycle p21/p57 (double p21(+/-)p57(+/-) mice) [7].
Mice deficient in these genes show failed sacculation at
term, respiratory distress at birth, and usually neonatal
death, while maintaining many normal features of the
peripheral lung. The targeted genes that result in dysmor-
phic sacculation encode proteins of different functional
Real time RT-PCR validation of selected genes identified by microarray analyses in E18.5 and term T1α null lungs Figure 4
Real time RT-PCR validation of selected genes identified by microarray analyses in E18.5 and term T1α null 
lungs. A. Expression levels obtained by microarray analysis of RNA from E18.5 wild type (+/+) lungs (relative value = 1, black 
bars) compared to E18.5 T1α (-/-) lungs (fold change relative to wild type, dotted bars) (n = 5). B. Real time RT-PCR validation 
of the genes depicted in A (n = 3-6). C. Expression levels obtained in the microarray analysis of RNA from term wild type (+/
+) lungs (relative value = 1, black bars) compared to term T1α (-/-) lungs (fold change relative to wild type, hatched bars) (n = 
3). D. Real time RT-PCR validation of the genes depicted in C. Data is normalized to actin expression level. (n = 3-6). Error 
bars represent standard error of the mean. (*) indicates p ≤ 0.05; (**) indicates p ≤ 0.01; (#) indicates p = 0.056.BMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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categories, such as transcription factors or membrane
receptors. It is noteworthy that null mutations of two
important alveolar epithelial proteins, T1α and gp330/
megalin [8,11], expressed in the apical membranes of type
I and type II cells respectively, disrupt sacculation. T1α
loss inhibits formation of expanded saccules, while loss of
gp330/megalin results in abnormally enlarged saccules
with cystic or emphysematous-like features [8].
While the identity of the genes knocked-out in the above
animals is obviously known, none of these models of
altered sacculation has been explored in detail to define
the molecular pathways that lead to their phenotype. T1α,
Sp3, GR, CRH, and megalin, for example, are all expressed
early in lung embryogenesis and in the lung thereafter
[14,22-25]. In those knock-outs there is considerable
uncertainty about the timing of molecular events that, in
Comparative expression analyses of mRNA and protein levels of EphrinA3 and Ptgs1 Figure 5
Comparative expression analyses of mRNA and protein levels of EphrinA3 and Ptgs1. Representative western blot 
and densitometry analysis of (A) EphrinA3 and (B) Ptgs 1 expression in total lung protein extracts (50 µg) at E18.5. Protein 
expression data are compared to the respective mRNA level determined by microarrays and QRT-PCR. Western blot data 
were normalized to the densitometry value of the Coomasie blue stained gels and total protein loaded. (+/+) indicates wild 
type, and (-/-) null genotypes respectively. n = 5 (E18.5) or 3 (term) for microarrays, n = 3 for QRT-PCR, and for western blot 
analyses for each genotype. Error bars represent standard error of the mean. (*) indicates p ≤ 0.05, (**) indicates p ≤ 0.01, (#) 
indicates p = 0.056.BMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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the end, affect sacculation. One could envision that the
accumulation of small molecular anomalies over time
might block a major morphogenetic event. To address this
question, we show here that the global gene expression
patterns of T1α null lungs at gestational day 18.5 and term
differ both from controls and from each other.
Comparison of microarray analyses of T1α-null and wild-
type lungs on day 18.5 shows changes in expression of
genes in several functional categories including transcrip-
tion factors, cell-cell interaction, enzymes, channels, and
others, that are reflected in overrepresentation of several
biological processes including vasculogenesis, protein tar-
geting, protein, metabolism, and mitosis. Among the cell-
cell interaction genes ephrinA3 is significantly up-regu-
lated in lungs showing narrow alveolar saccules. Ephrins
are surface bound proteins that interact with eph tyrosine
kinase receptors at sites of cell-cell interactions. The bidi-
rectional signaling generated by this interaction regulates
intercellular adhesion, cell shape and cell motility [26].
Ephrins, semaphorins, netrins and slit protein families
generate molecular cues to guide cell movement and tis-
sue morphogenesis [[27] and references therein].
Semaphorins, netrins and slit proteins appear to partici-
pate in early lung branching morphogenesis. In contrast
there is sparse information about the role of ephrins in the
lung. Several ephrinAs and ephA receptors are expressed
in adult lung suggesting that they can also participate in
cell-cell interaction in this organ. In particular ephrinA3 is
highly up-regulated in squamous lung cell carcinomas
[28]. The role of EphrinAs has been mostly studied in neu-
rons and vascular formation [29,30] but it is possible that
increased ephrinA3 in T1α(-/-) lungs alters the motility
and/or shape of distal lung cells resulting in abnormal
alveolar sac morphogenesis, a possibility that will require
further evaluation.
Several types of enzymes such as peptidases, ligases, and
others are affected at E18.5. One enzyme of particular
interest is Ptgs 1 (Cox-1) that is decreased in T1α knock-
out lungs. Ptgs1 catalyzes the production of PGE2 that is
the major prostaglandin species produced in the lung.
PGE2 is known to be a negative regulator of lung fibrob-
last proliferation in adult rodents. While many lung cells
can produce PGE2, murine alveolar epithelial cells are
immunoreactive for COX-1 protein and adult alveolar
type II epithelial cells have been directly shown to pro-
duce PGE2. Although the pattern of expression of Ptgs1 in
mouse fetal lung is not known [31], decreased epithelial-
derived prostaglandins due to a near absence of flattened
type I cells, might affect mesenchymal cells in term T1α(-
/-) lungs [32,33].
Biochemical data at term show that PCNA levels are
higher and p21 levels are lower than normal in T1α(-/-)
lungs. Microarray analyses of term T1α(-/-) lungs identify
additional genes likely involved in the hyperproliferation
phenotype of the term peripheral lung, such as FosB, Egr1,
MKP-1 and Nur77. These immediate early genes are sig-
nificantly down regulated. Changes in the expression of
these genes were not observed at day 18.5. FosB belongs
to the Ap-1 family of proteins regulated after mitogenic
stimulation. c-jun/fosB dimers inhibit cell proliferation
through binding to the Rb promoter [34]. Egr1 is a tran-
scription factor responsive to a variety of stress and
mitogenic signals that inhibits proliferation by activation
of p21 [35,36].  Reduced expression of Egr1 in T1α (-/-)
lungs may be involved in the down regulation of p21 tran-
scription observed at term. The transcription factor Nur77
(NGFI-B) is an orphan nuclear receptor that modulates
the retinoic acid signaling [37]. MKP-1 is a member of the
dual specificity protein phosphatases that inhibits G1 pro-
gression in response to growth factors. Decreases in MKP-
1 have been associated with increased proliferation [38].
MKP-1 transcription is up regulated by glucocorticoids
through the GR receptor [39]. The similar phenotype of
GR null lungs and T1α null lungs suggests that MKP-1
could be a common gene altered in these two mutant
mice that regulates distal lung differentiation. Although
all these changes point to possible abnormalities in cell
cycle regulation, exactly how this might work and what
the relationship between excess cell division and failure of
sacculation is, remain unclear. Based on studies of other
cells, decreased p21 would be expected to result in
increased cell proliferation in the affected cell popula-
tion(s). However because the net effects on cell cycle reg-
ulation are likely complex and dependent on the context
of the affected cells it will be important in future studies
to determine which lung cell types show alterations in
proliferation related genes. It is possible that proliferation
is repressed in some cell types while others are hyperpro-
liferative, and are PCNA positive. An important site of
decreased p21 expression is likely the type II cell which, in
the T1α knock-out mouse, continues to express PCNA
inappropriately near term. Although the sites of p21
expression are not well mapped in the fetal mouse lung,
p21 and pro-SP-B proteins colocalize in newborn baboon
lung under some conditions [40], and p21 mRNA is
expressed in peripheral lung of fetal mice as shown by in
situ hybridization [7]. If nascent type I cells are derived
from post-mitotic type II cells, withdrawal from the cell
cycle may be required before type I characteristics, includ-
ing the distinctive morphology, can be expressed. This
alone might affect sacculation. This possibility is consist-
ent with the failed sacculation, neonatal respiratory death,
and normal levels of surfactant proteins and CCSP in the
double p21(-/-)p57(+/-) knockout mouse [7].BMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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We have hypothesized that changes in gene expression
might be few and of small magnitude based on previous
northern analyses of null lungs at term [11]. Given the
striking phenotype of the term lung, the relatively small
change in many of the affected genes identified by micro-
array analysis, often between 1.5 and 2 fold, is notable.
Many of these changes are highly significant, however,
and are included in our assembled data because of the low
variance between samples. Although a >twofold differ-
ence has been conventional in considering genes as func-
tionally important, a number of previous studies have
also opted to use lower cut-off levels (1.2–1.5) [41-43]
when the changes are highly significant. In the T1α null
lung this issue may relate in part to the fact that the type I
cell comprises only about 10% of total lung cells; thus
even large fold changes in genes expressed by type I cell
precursors could be masked by lack of change of the same
gene in other cell populations. In this regard it would have
been useful to determine the fold changes in Aqp-5
mRNA by microarray because it is expressed only in type I
cells in the peripheral lung; however Aqp-5 mRNA is not
represented on the arrays we used.
Conclusion
This global analysis of gene expression has identified a
number of candidate genes that are significantly altered in
lungs in which sacculation is diminished and has linked
abnormal sacculation to alterations in the expression of
cell cycle regulators. Some of these genes may be involved
in the regulation of sacculation per se while others may be
expressed as a consequence of failed sacculation. Our
future studies will be directed towards further characteri-
zation of expression patterns genes identified, such as
ephrinA3, Ptgs1 and the cell cycle regulators, as prelimi-
nary to test their functions in the sacculation process.
Methods
Animals
Generation of T1α null mutant [T1α(-/-)] mice was
described previously [11]. T1α heterozygous [T1α(+/-)]
mice were bred to generate timed pregnancies. The pres-
ence of a vaginal plug at noon was considered day 0.5 of
pregnancy (E0.5). Fetuses were collected at E11.5, E15.5,
E18.5 and E19.5. Term animals were obtained within 10
min of normal delivery. Mice were euthanized following
IACUC-Boston University Medical Center approved pro-
cedures. Genomic DNA purified from a small piece of tail
tissue was used to genotype the animals by PCR. Briefly,
the targeting vector and/or endogenous T1α were detected
using the following conditions: we amplified ~450 bp of
the T1α promoter, absent in the targeted allele, using
genomic DNA, Taq polymerase (QIAGEN, Inc., Valencia,
CA), solution Q, 200 nM dNTPs, 94°C, 1 min; 50°C, 1
min; 72°C 2 min; 30 cycles; forward oligonucleotide (F)
TGAATGAATGTAGGAGCGAGCTG; reverse oligonucle-
otide (R) TTAGGCTCTGAACCCACAATGG. We also
amplified ~750 bp of the targeting sequence containing
part of the 5' arm of homology and of the neo sequence
using the same genomic DNA, Taq polymerase (QIA-
GEN), 1 mM MgCl2, 600 nM dNTPs, 94°C, 1 min; 60°C,
1 min; 72°C, 2 min; 30 cycles; forward oligonucleotide
CCTTCTTGACGAGTTCTTCTGAGG; reverse oligonucle-
otide GGTCTTATCAGTTAGCTTGTGG.
Histology and immunohistochemistry
E11.5 whole embryos or E15.5, 18.5, 19.5 and P1 dis-
sected lungs were fixed in 4% paraformaldehyde/PBS pH
7.4 solution and embedded in paraffin as described previ-
ously [14]. Sections of T1α(+/+) and (-/-) lungs (6 µm)
were stained with H&E to evaluate morphological
changes in the absence of T1α as described previously
[11]. T1α immunohistochemistry was performed as
described by Kotton et al [44]. Briefly, antigen retrieval
was performed by heating sections to 90°C in a citric acid
buffer (antigen retrieval solution; Vector Laboratories) for
20 minutes, slowly cooling to room temperature, and
prior to quenching. Sections were blocked with 1% goat
serum in PBS (60 minutes), incubated overnight (4°C)
with a monoclonal hamster anti-mouse T1α antibody
(Developmental Studies Hybridoma Bank, University of
Iowa, Hybridoma #8.1.1,[45]), and treated with HRP-
labeled goat anti-hamster IgG (ICN, Costa Mesa, CA) for
30 minutes at room temperature. Signals were amplified
using tyramide (TSA-Biotin System, NEN Life Science
Products, Boston, MA) according to the manufacturer's
protocol and exposed to diaminobenzidine for 6.5 min-
utes.
RNA isolation, labeling and microarray hybridization
Total RNA from E18.5 and term T1α(+/+) and T1α(-/-)
lungs was isolated (TRIzol method, Invitrogen, Carlsbad,
CA), re-purified using RNeasy Mini Kit (QIAGEN), and
DNase treated on column with DNA-free (Ambion, Inc.,
Austin TX). First and second strand syntheses were per-
formed as recommended by Affymetrix using 8 µg total
RNA as template. Biotin-labeled cRNA was generated
using the ENZO BioArray High Yield RNA transcript labe-
ling kit (Affymetrix, Santa Clara, CA). Each biotin-labeled
cRNA sample (15 µg) was hybridized (16 hours at 45°C
and 60 rpm) in an Affymetrix GeneChip System to the
Murine Genome U74 Av2 GeneChip (Affymetrix) that
contains ~12,000 sequences of the UniGene database or
ESTs [46]. Confocal laser scanning was performed with a
G2500A scanner (Agilent Technologies, Palo Alto, CA), to
detect the streptavidin-labeled fluor.
Microarray data acquisition
Five E18.5 T1α(+/+) lungs, five E18.5 T1α(-/-) lungs, three
term T1α(+/+) lungs and three term T1α(-/-) lungs were
analyzed on microarrays. A single weighted mean expres-BMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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sion level for each gene was derived using Microarray
Suite 5.0 software (MAS 5.0, Affymetrix). Using a one-
sided Wilcoxon signed-rank test, the MAS 5.0 software
generated a detection p-value for each gene indicating
whether or not the transcript was reliably detected. Data
from each array was scaled in order to normalize the
results for inter-array comparisons.
To filter out arrays of poor quality, several quality control
parameters on each array were assessed. We reviewed the
scanned image for significant artifacts, and the presence
on the array of bacterial genes spiked into the hybridiza-
tion mix (bioB and bioC). Background and noise meas-
urements were below 100 in all arrays. The average 3' to 5'
ratio of the signal for GAPDH was 1.01 ± 0.15 and for β-
actin was 1.63 ± 0.09 in E18.5 arrays. In term arrays, the
3' to 5' ratio for GAPDH was 1.63 ± 0.82 and for β-actin
was 1.72 ± 0.54. A ratio less than 3 is considered accepta-
ble. An average of 45.4 ± 3.8% probe sets exceeded the
probe pair threshold in all arrays (called 'present'). Corre-
lation values were calculated among arrays in the same
genotype and developmental group. The average correla-
tion values were: E18.5 T1α(-/-) (5 arrays) R2 = 0.953 +/-
0.023, E18.5 T1α(+/+) (5 arrays) R2 = 0.939 +/- 0.026,
term T1α(-/-) (3 arrays) R2 = 0.945 +/- 0.016, and term
T1α(+/+) (3 arrays) R2 = 0.931 +/- 0.026.
Microarray data analysis
Prior to performing statistical analyses, we selected genes
whose median detection p value was ≤ 0.05 (called
'present') in at least one of the 2 comparative groups (+/+
or -/-). To compare T1α(-/-) lung gene expression vs.
T1α(+/+) at E18.5 (n = 5 each) or at term (n = 3 each), a
Student's t-test was performed with a p-value less than
0.05 considered significant (Tables S1 and S2, Additional
file 3). A Mann-Whitney test [18] was also performed
given that expression levels of many genes did not follow
a Gaussian distribution (Tables S3 and S4, Additional file
3). Due to the limited sample size, absolute correction for
multiple comparisons was not performed. The magnitude
of change in gene expression was calculated as the ratio of
the average (arithmetic mean) signal in (-/-) lungs divided
by the average signal in (+/+) at each time point and
expressed as positive fold change (genes up regulated) or
negative fold change (genes down regulated). Functional
classification of differentially expressed genes was derived
from the Gene Ontology annotation [47], and current lit-
erature. Microarray data have been deposited in the
National Center for Biotechnology Information (NCBI)
Gene Expression Omnibus (GEO) database [48].
GSE1363 is the GEO accession number for the series
object that summarizes the experiments and provides
links to all other relevant accessions [49].
Over-represented functional categories or "themes"
altered in the absence of T1α at E18.5 and at term were
identified using the EASE application [50]. EASE analyzes
a list of Affymetrix ID numbers of the genes under study
(input list) and finds over-represented biological
"themes" in the list of genes, compared to the total
number of genes for each biological theme in the array.
The significance of each category is determined by two sta-
tistical values that are used to sort the categories, i.e. the
standard Fisher exact probability, and a conservative EASE
score that identifies robust categories. We considered cat-
egories with an EASE score ≤ 0.05 as over-represented.
Real Time RT-PCR
Selected genes differentially expressed in the microarray
analysis, not previously linked to alveolar sac formation,
were evaluated by real time RT-PCR (QRT-PCR). E18.5
and term total RNA, treated with DNA-free DNase
(Ambion), was reversed transcribed (RT) (1 µg in 25 µl)
using AMV reverse transcriptase (Promega, Madison, WI).
RT reactions diluted 1:32 were analyzed by QRT-PCR in
an ABI 7000 instrument (Applied Biosystems, Foster City,
CA). Primers were designed using PrimerExpress version
2.0 software (Applied Biosystems) or were obtained from
Assays-on-Demand (Applied Biosystems). Reactions were
performed in 50 µl using either TaqMan PCR universal
master mix or SybrGreen PCR master mix (Applied Bio-
systems). For all primers and probes, optimal concentra-
tions were found and dissociation curves were performed
for primers used in SybrGreen reactions to confirm a sin-
gle product. The relative concentration of RNA for each
gene tested was obtained using calibration curves per-
formed with wild type E18.5 or term total lung RNA (n =
3), respectively. Samples and calibration curves were
reverse transcribed and amplified under equal conditions.
E18.5 T1α (+/+), E18.5 T1α (-/-), term T1α (+/+), and
term T1α (-/-) lungs were analyzed in duplicate (n = 3-6).
Data were normalized to β-actin mRNA at E18.5 and at
term; the level of expression of β-actin mRNA does not
change between T1α(+/+) and T1α(-/-) samples at the
respective time point. Oligonucleotides used in
SybrGreen reactions were: Additional sex combs like (F)
TCTTCCGCCATTTCATCTGA, (R) CACAACATGGACTT-
GGCCAA; Complement C1qa (F) GTGAAAGGCAATC-
CAGGCAA, (R) TGGTTGGTGAGGACCTTGTCA; Cyr61
Applied Biosystems Assays-on-Demand; Dual specificity
phosphatase 1 (MKP-1) (F) ATGCTTGACACACCCAC-
CAGT, (R) TCATACGCGCATGTCATCG; Dynein cytoplas-
mic (F) AAATCCACCCCAGCGTTTCTAC, (R)
CCCCATTTGTTTTTGAGACGG; Early growth response 1
(F) TTTCAGCCTGAGTCCTTACCCA, (R) TGCATGGT-
CAGTTCCCAGAAC; Ephrin A3 (F) TGCCCCCTTCCTAT-
GACAGAGAG, (R) GCCCAGAGAGATGTACAGTGCA;
FosB (F) CGGCCTCTCCCTTTATCCTTT, (R) TGTC-
CCCGACAAATCCAGAA; Gas5 (F) TTCATTTGGCT-BMC Developmental Biology 2006, 6:35 http://www.biomedcentral.com/1471-213X/6/35
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GGCTTGCTT, (R) GGAATTCAAGGCCCCCAAT; Nuclear
receptor subfamily 4A1/Nur77 (F) CCAGCCTGGTTTT-
GAGCTAAG, (R) CCATCTTCTGGAGTGAGGAGGT;
OTS8/T1α (F) TGGCGTCTTGTTAGCCATTG, (R)
GGCGAGACCTTCCAGAAATC; Prostaglandin-endoper-
oxide synthase 1 (F) CAAACCTACGTCTACGCCAA, (R)
AGTCCATCTGTTCCCTCCAC; Rb1 (F) GAATTCTCAGA-
GATCTTGCTTCG, (R) AGTGGAGTGTCTGCAGCTT-
TAAG; Sp1 (F) CACCCAGTGCCAGAGACATATG, (R)
CCAATTCTTCCTACCACCAAGC.
Northern blots
Total lung RNA (10 µg) was electrophoresed, blotted and
hybridized as described previously [11]. p21 probe was a
gift of C. X. Deng, NIDDKD, NIH, Bethesda, MD). p27
and p57 probes were generated by RT-PCR (p27 forward
oligonucleotide CGGGATATGGAAGAAGCGAGTC,
reverse TTTACGTCTGGCGTCGAAGG; p57 forward oligo-
nucleotide GCCAATGCGAACGACTTCTT, reverse
AGAGTTCTTCCATCGTCCGCT). Data were normalized
to β-actin [12].
Western blots
E18.5 and term lung proteins were extracted using RIPA
buffer [14]. Protein extracts (10–20 µg) were electro-
phoresed in a 12% SDS/polyacrylamide gel, blotted on
PVDF membranes, or nitrocellulose for p57, and analyzed
under similar conditions using PCNA, p21, p27, and p57
antibodies (Santa Cruz Biotechnologies, Inc., Santa Cruz,
CA) as described previously [11]. EphrinA3 was analyzed
in a 4% SDS/polyacrylamide gel, blotted on PVDF mem-
branes and analyzed using ephrinA3 H-90 (1:1000) and
cox-1 M-20 (1:500) antibodies (Santa Cruz Biothechnol-
ogies, Inc.). Histone H1 FL-219 (Santa Cruz), β-actin
Clone AC-15 (Sigma, Saint Louis, MO) and tubulin-α
(Sigma) were tested but discarded as potential controls for
western blot loading because all three proteins show a
higher expression in T1α(-/-) lungs compared to T1α(+/+)
at term (data not shown). Therefore we used total amount
of protein loaded as the normalization value, and Cooma-
sie blue staining of the gel, where noted (n = 2-3, in trip-
licate).
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